ITRM vs LMT · rev $390.0K vs P/E 20, rev $75.05B
Iterum Therapeutics PLC (ITRM) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
ITRM currently screens at market cap $38.6M. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the ITRM and LMT stock pages for the full models.
Not investment advice.